128 related articles for article (PubMed ID: 31493026)
21. Membrane transporters as mediators of cisplatin side-effects.
Ciarimboli G
Anticancer Res; 2014 Jan; 34(1):547-50. PubMed ID: 24403515
[TBL] [Abstract][Full Text] [Related]
22. Aging increases the susceptibility of cisplatin-induced nephrotoxicity.
Wen J; Zeng M; Shu Y; Guo D; Sun Y; Guo Z; Wang Y; Liu Z; Zhou H; Zhang W
Age (Dordr); 2015 Dec; 37(6):112. PubMed ID: 26534724
[TBL] [Abstract][Full Text] [Related]
23. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity.
Yokoo S; Yonezawa A; Masuda S; Fukatsu A; Katsura T; Inui K
Biochem Pharmacol; 2007 Aug; 74(3):477-87. PubMed ID: 17582384
[TBL] [Abstract][Full Text] [Related]
24. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
[TBL] [Abstract][Full Text] [Related]
25. Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats.
González R; Romay C; Borrego A; Hernández F; Merino N; Zamora Z; Rojas E
Mediators Inflamm; 2005 Aug; 2005(3):139-43. PubMed ID: 16106099
[TBL] [Abstract][Full Text] [Related]
26. Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics.
Higgins JW; Bedwell DW; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2012 Jun; 40(6):1170-7. PubMed ID: 22407892
[TBL] [Abstract][Full Text] [Related]
27. Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice.
Huang KM; Leblanc AF; Uddin ME; Kim JY; Chen M; Eisenmann ED; Gibson AA; Li Y; Hong KW; DiGiacomo D; Xia SH; Alberti P; Chiorazzi A; Housley SN; Cope TC; Sprowl JA; Wang J; Loprinzi CL; Noonan A; Lustberg MB; Cavaletti G; Pabla N; Hu S; Sparreboom A
J Clin Invest; 2020 Sep; 130(9):4601-4606. PubMed ID: 32484793
[TBL] [Abstract][Full Text] [Related]
28. Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury.
Ulu R; Dogukan A; Tuzcu M; Gencoglu H; Ulas M; Ilhan N; Muqbil I; Mohammad RM; Kucuk O; Sahin K
Food Chem Toxicol; 2012 May; 50(5):1675-9. PubMed ID: 22414646
[TBL] [Abstract][Full Text] [Related]
29. Involvement of Organic Cation Transporters in the Kinetics of Trimethylamine N-oxide.
Miyake T; Mizuno T; Mochizuki T; Kimura M; Matsuki S; Irie S; Ieiri I; Maeda K; Kusuhara H
J Pharm Sci; 2017 Sep; 106(9):2542-2550. PubMed ID: 28479364
[TBL] [Abstract][Full Text] [Related]
30. Reply to the letter addressed by Amr A. EL-Arabey "Dual function of OCT-2 and MATE1 in Cisplatin induced nephrotoxicity".
Thomas F
Pharmacol Res; 2017 May; 119():494. PubMed ID: 27890819
[No Abstract] [Full Text] [Related]
31. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T
Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 deficiency accelerates cisplatin-induced acute renal failure but not systemic injury.
Mitazaki S; Kato N; Suto M; Hiraiwa K; Abe S
Toxicology; 2009 Nov; 265(3):115-21. PubMed ID: 19833167
[TBL] [Abstract][Full Text] [Related]
33. Absence of Sirt3 aggravates cisplatin nephrotoxicity via enhanced renal tubular apoptosis and inflammation.
Kim D; Park W; Lee S; Kim W; Park SK; Kang KP
Mol Med Rep; 2018 Oct; 18(4):3665-3672. PubMed ID: 30106119
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2.
Gebauer L; Arul Murugan N; Jensen O; Brockmöller J; Rafehi M
Biochem Pharmacol; 2022 Mar; 197():114871. PubMed ID: 34902340
[TBL] [Abstract][Full Text] [Related]
35. Antigenotoxic properties of chlorophyll b against cisplatin-induced DNA damage and its relationship with distribution of platinum and magnesium in vivo.
Serpeloni JM; Batista BL; Angeli JP; Barcelos GR; Bianchi Mde L; Barbosa F; Antunes LM
J Toxicol Environ Health A; 2013; 76(6):345-53. PubMed ID: 23557233
[TBL] [Abstract][Full Text] [Related]
36. Magnesium attenuates cisplatin-induced nephrotoxicity by regulating the expression of renal transporters.
Saito Y; Okamoto K; Kobayashi M; Narumi K; Yamada T; Iseki K
Eur J Pharmacol; 2017 Sep; 811():191-198. PubMed ID: 28529140
[TBL] [Abstract][Full Text] [Related]
37. Role of Organic Cation Transporter 2 in Autophagy Induced by Platinum Derivatives.
Eltayeb SA; Ciarimboli G; Beul K; Seno Di Marco G; Barz V
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163014
[TBL] [Abstract][Full Text] [Related]
38. Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity.
Bulacio RP; Torres AM
Arch Toxicol; 2013 Nov; 87(11):1953-1962. PubMed ID: 23649842
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin-induced nephrotoxicity in patients with advanced neuroblastoma.
Yanagisawa R; Kubota N; Hidaka E; Sakashita K; Tanaka M; Nakazawa Y; Nakamura T
Pediatr Blood Cancer; 2018 Sep; 65(9):e27253. PubMed ID: 29797635
[No Abstract] [Full Text] [Related]
40. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
